TGFβ-enhanced invasive capacity of pancreatic cancer cells cross-talks extensively with ROS signalling and is mediated by Rac1, NFκB, IL-6 and MMP-2 [37]. The gene discussed is TGFB1; the disease is familial pancreatic carcinoma.